BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 37033250)

  • 1. Acidosis-induced regulation of adipocyte G0S2 promotes crosstalk between adipocytes and breast cancer cells as well as tumor progression.
    Cremer J; Brohée L; Dupont L; Lefevre C; Peiffer R; Saarinen AM; Peulen O; Bindels L; Liu J; Colige A; Deroanne CF
    Cancer Lett; 2023 Aug; 569():216306. PubMed ID: 37442366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathogenesis of Diabetes.
    Guo H; Wu H; Li Z
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells.
    Corbet AK; Bikorimana E; Boyd RI; Shokry D; Kries K; Gupta A; Paton A; Sun Z; Fazal Z; Freemantle SJ; Nelson ER; Spinella MJ; Singh R
    Transl Oncol; 2023 Jul; 33():101676. PubMed ID: 37086619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of
    Wu D; Zhang Z; Sun W; Yan Y; Jing M; Ma S
    Front Endocrinol (Lausanne); 2023; 14():1130350. PubMed ID: 37033250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-specific G
    Sugaya Y; Satoh H
    J Diabetes; 2017 Aug; 9(8):754-763. PubMed ID: 27624922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the gene encoding G0/G 1 switch protein 2 (G0s2) alleviates high-fat-diet-induced weight gain and insulin resistance, and promotes browning of white adipose tissue in mice.
    El-Assaad W; El-Kouhen K; Mohammad AH; Yang J; Morita M; Gamache I; Mamer O; Avizonis D; Hermance N; Kersten S; Tremblay ML; Kelliher MA; Teodoro JG
    Diabetologia; 2015 Jan; 58(1):149-57. PubMed ID: 25381555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis.
    Zhang X; Xie X; Heckmann BL; Saarinen AM; Czyzyk TA; Liu J
    Diabetes; 2014 Mar; 63(3):934-46. PubMed ID: 24194501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism.
    Wang Y; Zhang Y; Qian H; Lu J; Zhang Z; Min X; Lang M; Yang H; Wang N; Zhang P
    PLoS One; 2013; 8(8):e72315. PubMed ID: 23951308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.
    Wang X; Liu M; Zhang J; Brown NK; Zhang P; Zhang Y; Liu H; Du X; Wu W; Devenport M; Tao W; Mao-Draayer Y; Chen GY; Chen YE; Zheng P; Liu Y
    Cell Metab; 2022 Aug; 34(8):1088-1103.e6. PubMed ID: 35921817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic RNA-silencing oligonucleotides in metabolic diseases.
    Goga A; Stoffel M
    Nat Rev Drug Discov; 2022 Jun; 21(6):417-439. PubMed ID: 35210608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-CpG-binding domain protein 2 contributes to renal fibrosis through promoting polarized M1 macrophages.
    Ai K; Pan J; Zhang P; Li H; He Z; Zhang H; Li X; Li Y; Yi L; Kang Y; Wang Y; Xiang X; Chai X; Zhang D
    Cell Death Dis; 2022 Feb; 13(2):125. PubMed ID: 35136032
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.